<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01689402</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2012-009</org_study_id>
    <nct_id>NCT01689402</nct_id>
  </id_info>
  <brief_title>MRI for the Early Evaluation of Acute Intracerebral Hemorrhage</brief_title>
  <official_title>MRI for Early Identification of Underlying Pathology in Patients With Acute Intracerebral Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      What happens in the borderzone of a cerebral hemorrhage remains widely onknown and furhter
      the best timing for doing MR to look for vascular pathology in cerebral hemorrhage has not
      yet been determined. In this study we do acute MRS, a non-invasive imaging mathod to detemine
      the biochemsty in the border zone and structural MRI for vascular malformation. We repeat
      structural MRI after 8 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we want to investigate the ability of MRI to identify underlying pathology
      (tumor or vascular malformations) in acute patients admitted with intracerebral hemorrhage
      (ICH). Today MRI-scan is normally done 3-4 weeks after symptom onset but very little is known
      about the early use of MRI to detect underlying pathology. This would allow an early
      intervension and less uncertainty for the patients.

      We further want to investigate the metabolic penumbra-zone surrounding the hematoma. It is
      the current perception in the litterature that this zone represent a metabolic zone marked by
      apoptosis and inflammation rather than ischemia.

      We are planning to:

      When patients arrive in our stroke department they will within 7 hours be subject to MRI scan
      with the protocoled sequences. Standard sequences: Axial T2, axial DWI, Sagittal T1, T2 flair
      og axial GRE-sequence.

      Susceptibility weighted imaging (SWI)

      Chemical Shift Imaging (CSI) multivoxel spectroscopi

      Post contrast 3D box reconstruction

      After 8 weeks the patients are subject to another MRI-Scan in accordance with the standard
      clinical guideline to rule out underlying pathology.

      After 3 month the patients are seen in the outpatient-clinic to follow-up evaluation.

      To sum up the purpose of this present study is to conduct a pilot investigation of MRI in the
      early evaluation of ICH-patients. Second it is our intension to use multivoxel magnetic
      resonance spectroscopy to study the metabolic penumbra-zone surrounding the ICH.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>early correct diagnosis of underlying vascular malformation</measure>
    <time_frame>8 weeks</time_frame>
    <description>Correct diagnosis based on findings on 8 weeks control MRI</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Hemorrhage</condition>
  <condition>Intracranial Arteriovenous Malformations</condition>
  <condition>Intracranial Hemorrhage, Hypertensive</condition>
  <condition>Brain Neoplasms</condition>
  <arm_group>
    <arm_group_label>Intracerebral Hemorrhage Patients</arm_group_label>
    <description>Patients admitted with acute intracerebral hemorrhage within 72 hours after symptom onset.Patients are included in the study for MRI studies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI Scan with the specified sequences below:</intervention_name>
    <description>Standard sequences: Axial T2, axial DWI, Sagittal T1, T2 flair og axial GRE-sequence.
Susceptibility weighted imaging (SWI)
Chemical Shift Imaging (CSI) multivoxel spectroscopi
Post contrast 3D box reconstruction</description>
    <arm_group_label>Intracerebral Hemorrhage Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted with CT-demonstrated Intracerebral Hemorrhage (ICH) within 72 hours after
        symptom onset.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CT demonstrated ICH

          -  Cardiopulmonary stable

          -  Informed consent from patient or proxy

          -  No General contraindication of MRI

          -  Age above 18

        Exclusion Criteria:

          -  Lack of informed consent

          -  lack of cooperability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hanne Christensen, MD, DMSci</last_name>
    <phone>004521729416</phone>
    <email>hchr0039@bbh.regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anders Christensen, MD, Ph.d</last_name>
    <email>achr0019@bbh.regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bispebjerg University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Capital Region</state>
        <zip>DK-2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanne Christensen, MD, Ph.d, DMSci</last_name>
      <email>hchr0039@bbh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Hanne Christensen, MD, Ph.d, DMSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anders F Christensen, MD, Ph.d</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Sahni R, Weinberger J. Management of intracerebral hemorrhage. Vasc Health Risk Manag. 2007;3(5):701-9. Review.</citation>
    <PMID>18078021</PMID>
  </reference>
  <reference>
    <citation>Delgado Almandoz JE, Schaefer PW, Goldstein JN, Rosand J, Lev MH, Gonz√°lez RG, Romero JM. Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score. AJNR Am J Neuroradiol. 2010 Oct;31(9):1653-60. doi: 10.3174/ajnr.A2156. Epub 2010 Jun 25.</citation>
    <PMID>20581068</PMID>
  </reference>
  <reference>
    <citation>Wijman CA, Venkatasubramanian C, Bruins S, Fischbein N, Schwartz N. Utility of early MRI in the diagnosis and management of acute spontaneous intracerebral hemorrhage. Cerebrovasc Dis. 2010;30(5):456-63. doi: 10.1159/000316892. Epub 2010 Aug 24.</citation>
    <PMID>20733299</PMID>
  </reference>
  <reference>
    <citation>Diedler J, Karpel-Massler G, Sykora M, Poli S, Sakowitz OW, Veltkamp R, Steiner T. Autoregulation and brain metabolism in the perihematomal region of spontaneous intracerebral hemorrhage: an observational pilot study. J Neurol Sci. 2010 Aug 15;295(1-2):16-22. doi: 10.1016/j.jns.2010.05.027. Epub 2010 Jun 16.</citation>
    <PMID>20557898</PMID>
  </reference>
  <reference>
    <citation>Carhuapoma JR, Wang PY, Beauchamp NJ, Keyl PM, Hanley DF, Barker PB. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke. 2000 Mar;31(3):726-32.</citation>
    <PMID>10700511</PMID>
  </reference>
  <reference>
    <citation>Carhuapoma JR, Wang P, Beauchamp NJ, Hanley DF, Barker PB. Diffusion-perfusion MR evaluation and spectroscopy before and after surgical therapy for intracerebral hemorrhage. Neurocrit Care. 2005;2(1):23-7.</citation>
    <PMID>16174964</PMID>
  </reference>
  <reference>
    <citation>Karaszewski B, Thomas RG, Chappell FM, Armitage PA, Carpenter TK, Lymer GK, Dennis MS, Marshall I, Wardlaw JM. Brain choline concentration. Early quantitative marker of ischemia and infarct expansion? Neurology. 2010 Sep 7;75(10):850-6. doi: 10.1212/WNL.0b013e3181f11bf1.</citation>
    <PMID>20819997</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2012</study_first_submitted>
  <study_first_submitted_qc>September 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2012</study_first_posted>
  <last_update_submitted>July 15, 2014</last_update_submitted>
  <last_update_submitted_qc>July 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Hanne Christensen</investigator_full_name>
    <investigator_title>Associate Research Professor, Consultant Neurologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Intracranial Arteriovenous Malformations</mesh_term>
    <mesh_term>Intracranial Hemorrhage, Hypertensive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

